Scinai Immunotherapeutics (SCNI) Enterprise Value (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Enterprise Value for 2 consecutive years, with -$1.8 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 13.56% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Dec 2025, up 13.56% year-over-year, with the annual reading at -$1.8 million for FY2025, 13.56% up from the prior year.
- Enterprise Value hit -$1.8 million in Q4 2025 for Scinai Immunotherapeutics, up from -$2.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.8 million in Q4 2025 to a low of -$2.1 million in Q4 2024.